Horizon Discovery Arrayed CRISPR Knockout Screening for Primary Human B Cells

Horizon Discovery has added an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services. The new B cell screening service will enable researchers to identify genes that affect the function of B cells and examine how this impacts other immune cell types, particularly in infectious diseases, cancer, and auto-immune disorders, such as COVID-19, Burkitt's lymphoma, and multiple sclerosis, the company said.